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Objective: Immunological mechanisms are involved in the pathophysiology of preec-
lampsia. During pregnancy there is an increase in regulatory T (Treg) cells, which has
an important role in regulating tolerance to the immunologically distinct fetus.
We hypothesised that percentages of Treg cells are decreased in preeclamptic
patients. Methods: Peripheral blood was obtained from 26 healthy pregnant controls
and 18 preeclamptic patients. Treg cells were measured using flow-cytometry. Results:
Women with pregnancies complicated by preeclampsia had significantly lower percentages
of CD4+FOXP3+ Treg cells. Conclusion: We conclude that a deficiency of regulatory
T cells may play a role in the pathophysiology of preeclampsia.
Keywords Case-control study, Cell biology, Inflammation, Preeclampsia, Pregnancy.
INTRODUCTION
Despite great advances in pre- and perinatal care it is estimated that worldwide
more than 50,000 women die from preeclampsia per year (1). In developed
countries preeclampsia is responsible for 15–20% of maternal mortality (2).
Preeclampsia can manifest as a maternal syndrome (hypertension, proteinuria
Address correspondence to Jan Jaap H.M. Erwich, University Medical Center



















































Decreased Tregs in Preeclampsia 301
and oedema) and/or a fetal syndrome (fetal and placental growth restriction,
reduced amniotic fluid and abnormal oxygenation) (3). The etiology and patho-
genesis of preeclampsia are not fully known (1,2,4,5). However, abundant
evidence suggests that immunological factors are crucial for the development
of this disease (2,6,7).
For several years the Th1-Th2 paradigm has been used to explain the
maternal tolerance towards the fetus. During normal pregnancy the mater-
nal immune system shifts to a pre-dominant Th2 response, which is
thought to be important in tolerance to the immunological distinct fetus
(7,8). The shift to a pre-dominant Th2 response probably does not occur or is
reversed at some point during gestation in patients with pregnancies com-
plicated by preeclampsia (6,7,9). Th1 dominance develops together with an
increased inflammatory response towards the fetus (10). However,
this explanation has been quest in light of recent research, and it has
become clear that additional regulatory mechanisms play a role in the fetal-
maternal tolerance (10,11). Regulatory T (Treg) cells are regarded as hav-
ing an important role in regulating the immune response and tolerance to
the fetus (8,10,12,13). Normal pregnancy is associated with an elevation of
Treg cells in maternal blood and decidua (8,14,15). As Treg cells can also
suppress NK cells and NKT cells, in terms of proliferation and cytokine pro-
duction, they might suppress type-1 responses in normal pregnancy by this
route (10).
Treg cells are a subpopulation of CD4+CD25+ lymphocytes specifically
characterized by the lineage specific transcription factor Forkhead Box P3
(FOXP3) (13,16–19). It has been shown that Treg cell function requires the
expression of FOXP3 (17,19,20). Treg cells are furthermore characterised
based on expression of several surface markers; besides CD25, these include
GITR (glucocorticoid-induced TNFR) and CTLA-4 (cytotoxic T-lymphocyte
associate protein 4, CD152), whose expression on Treg cells is dependent on
FOXP3 (13,21).
Several studies have been published describing an association between a
decreased level of Treg cells in peripheral blood and preeclampsia, however
the methods and results are not consistent (22–26). Furthermore, most of
these studies used CD25 as a Treg cell marker. However surface markers such
as CD25 are also dynamically expressed on the surface of newly activated
CD4+ T-helper cells. Using the intracellular marker Foxp3 is therefore supe-
rior and more accurate. Interestingly, some studies have shown an association
between preeclampsia and changed levels of T cell subpopulations in umbili-
cal cord blood, showing an alteration in the immunological parameters of the
newborn (27,28).
The aim of this study was to investigate any association between pregnan-
cies complicated by preeclampsia and levels of Treg cells in peripheral maternal


















































302 Prins et al.
umbilical cord blood samples from women whose pregnancies were compli-
cated by preeclampsia and samples from women with a normal pregnancy.
MATERIAL AND METHODS
Patient Details
This study was approved by the Medical Ethical Committee at the University
Medical Center Groningen (UMCG). Women were recruited from the department
of Obstetrics and Gynaecology of UMCG, the Netherlands. All women gave
written informed consent. In total, 18 women with pregnancies complicated by
preeclampsia and 26 healthy pregnant controls were enrolled in this study.
The healthy controls were divided in two groups; term (control group I) and
preterm (control group II). Control group I consisted of eighteen healthy preg-
nant women at term, opting for elective Caesarean section. Since almost all
the women with preeclampsia delivered preterm, control group II (peripheral
blood only) consisted of 8 women during normal pregnancy with a gestational
age matched for the preterm preeclamptic group to determine the possible
influence of pregnancy length on the levels of Treg cells.
Preeclampsia was defined as gestational hypertension (systolic blood
pressure ≥140 mmHg and/or a diastolic blood pressure ≥90 mmHg after 20th
week of gestation) combined with significant proteinuria (≥300 mg/24 hour).
Women with other disorders of the immune system or using (other) immune
suppressing medication were excluded from this study.
Samples
Peripheral blood and umbilical cord blood samples were collected in
Lithium-heparin tubes. All peripheral blood samples were obtained well
before the onset of labor or caesarean section. Due to logistic circumstances
and transfers of the patients it was only possible to collect an umbilical cord
blood sample of 8 preeclamptic patients and 16 healthy controls.
Analysis of Regulatory T Cells by Flow-Cytometry
First, the samples were divided into a tube for intracellular staining and
one for extracellular staining, as the protocols are different. Staining for
FOXP3 (intracellular staining). In each test tube 200 μl whole blood was
pipetted, after washing the blood with PBS and centrifugation, the superna-
tant was discarded. The cells were fixed and permeabilised using a fixation-
permeabilization buffer (eBioscience, USA), and incubated for 30 minutes at
4°C. The cells were then washed once with PBS solution and twice with
permeabilization buffer (eBioscience, USA). This was followed by incubation
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binding. The cells were then incubated for 30 minutes at 4°C with PerCP-,
APC- and PE- labelled antibodies against CD4, CD25 and FOXP3, respec-
tively, or appropriate isotype controls. The PE anti-human FoxP3 staining set
was obtained from eBioscience, USA, all the other antibodies were purchased
from BD Pharmingen, USA.
This was followed by washing twice with permeabilization buffer, after
which the cells were resuspended in 400 μl FACS buffer, consisting of PBS,
1% BSA and 0,1% NaN3. Samples were analysed on the FACSCalibur
TM
within 4 hours.
Staining for CTLA-4 and GITR (cell surface staining): First the antibodies
(CD4-Per-CP, CD25-APC, CTLA4-PE and GITR-FITC) or appropriate isotype
controls were pipetted in FACS tubes. Then 200 μl whole blood was added to
each tube. After the cells were incubated for 15 minutes at 20°C, red blood
cells were lysed with IQ-lyse (IQ products, Groningen, the Netherlands) and
stored for 10 minutes in the dark at 20°C. Hereafter demineralised water was
added and the tubes were stored again for 10 minutes at 20°C. Then cells were
resuspended in 400 μl FACS buffer. Samples were analysed on the FACSCali-
burTM within 4 hours.
For each sample 50,000 cells were acquired for analysis. Cells were
measured using a BD FACSCaliburTM with CELLQuestTM software. For the
acquisition a real time gate was placed around the lymphocytes based on their
forward scatter/side scatter profile, avoiding other cell populations. Subse-
quently the cells were analysed using Winlist 6.0. Cell populations were
identified based on histograms and dot plots. A CD25high subpopulation was
identified within the CD25+ population (see Figure 1).
Statistics
For the comparison of the obstetric and maternal characteristics between
the cases and controls the Mann-Whitney U-test and Fisher’s exact test were
used. SPSS software was used for this, p-values <0.05 were considered to
be significant. Graphpad Prism was used for designing of the graphs. For the
analysis of the frequencies of cells that stained positively with different
antibodies the Mann-Whitney test was used.
RESULTS
The frequency of CD4+CD25highFOXP3+ cells in peripheral maternal blood
was not significantly decreased in women with preeclampsia. However, the
frequency of CD4+FOXP3+ T cells in peripheral blood was significantly lower
in women with preeclampsia than in healthy pregnant controls (p < 0.01), for
the frequencies of T cells that stained positively with the superficial markers


















































304 Prins et al.
increased percentage of CD4+CD25+ T cells (p < 0.01), the frequencies of T
cells that stained positively with both the extracellular and intracellular
markers in umbilical cord blood were comparable in both groups (Table 2).
Delivery was vaginal in 3 cases of preeclampsia, all other women under-
went a caesarean section. Significant differences were found between the
healthy pregnant controls and the preeclamptic women for parity, gestational
age, infant weight and usage of corticosteroids. These differences were
expected based on known associations with preeclampsia. A significant differ-
ence between the preeclamptic women and the gestational age matched
Figure 1: Expression of CD25 in CD4+ cells. The gates are set with help of isotype controls.
Table 1: Comparison of percentages of T cells that stained positively with different 
antibodies in peripheral blood between the cases and controls (levels as 
percentage of CD4+ cells).
Healthy 
controls (n = 26)
Preeclamptic 
women (n = 18) Significance
Maternal blood (mean ± SD)
CD4+ FOXP3+ 8.8 ± 5.4 4.5 ± .2.8 S
CD4+ CD25+ 5.4 ± 2.8 6.0 ± 2.1 NS
CD4+ CD25high FOXP3+ 1.5 ± 1.2 0.92 ± 0.95 NS
CD4+ CD25high CTLA-4+ 1.1 ± 0.77 0.95 ± 0.46 NS
CD4+ CD25high GITR+ 0.20 ± 0.34 0.21 ± 0.19 NS
CD4+ CD25high CTLA-4+ GITR+ 0.25 ± 0.25 0.23 ± 0.22 NS
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controls was found for the usage of corticosteroids (table 3), which was also
expected.
According to the time of onset, preeclampsia can be divided in two sub-
groups, namely, the early and the late onset forms. To investigate if there was
a relationship between percentages of Treg cells and gestational age in women
with and without preeclampsia, we divided all the subjects into pre-term
Table 2: Comparison of percentages of T cells that stained positively with different 
antibodies in umbilical cord blood between the cases and controls (levels as 
percentage of CD4+ cells).
Healthy 
controls (n = 16)
Preeclamptic 
women (n = 8) Significance
Umbilical cord blood (mean ± SD)
CD4+ FOXP3+ 7.2 ± 3.3 7.9 ± 4.8 NS
CD4+ CD25+ 7.0 ± 1.7 9.4 ± 1.8 S
CD4+ CD25high FOXP3+ 1.9 ± 1.1 1.5 ± 2.0 NS
CD4+ CD25high CTLA-4+ 1.9 ± 1.0 2.4 ± 1.7 NS
CD4+ CD25high GITR+ 0.29 ± 0.36 0.25 ± 0.25 NS
CD4+ CD25high CTLA-4+
GITR + 0.46 ± 0.45 0.38 ± 0.36 NS
SD = standard deviation; NS = not significant; S = significant; p < 0.01.
















32.2 ± 4.3 30.3 ± 6.1 NS† 32.6 ± 6.0 NS†
(mean ± SD)
Parity
primiparous 6 (33.3) 15 (83.3) S‡ 6 (75.0) NS‡
multiparous 12 (66.7) 3 (16.7) 2 (25.0)
Gestational age 
(days)
275.5 225.0 S† 236.0 NS†




(mean, range ) 2420–4540 750–4130
Smoking 5 (27.8) 1 (5.6) NS‡ 1 (12.5) NS‡
Corticosteroids 0 (0.0) 12 (66.7) S‡ 0 (0.0) S‡
The numbers in parentheses represent the percentage of women in each group.
SD = standard deviation; NS = not significant; S = significant; p < 0.05.
Significance I = significance between healthy controls and preeclamptic women.
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(<259 days of gestational age) and term (≥259 days of gestational age) group
(Figure 2). No significant differences were found for the CD4+CD25highFOXP3
staining (Figure 2A). However there was a decreased level of CD4+CD25high
FOXP3 cells in preeclamptic patients (Figure 2A). The pre-term group of preg-
nancies complicated by preeclampsia showed a significantly lower percentage
of CD4+ FOXP3+ cells in peripheral blood compared to the healthy pregnant
controls (Figure 2B). At term this percentage was also lower but not signifi-
cantly so. Between pre-term and term pregnancies complicated by preeclamp-
sia no significant difference was found in the percentage of CD4+ FOXP3+
Treg cells (Figure 2B).
Furthermore, our data shows a small increase in the percentage of
CD4+FOXP3+ cells in preeclamptic women using corticosteroids, compared to
Figure 2: Comparison of the frequency of CD4+CD25high FOXP3+ cells (A) and CD4+ FOXP3+ 
cells (B) in peripheral maternal blood (levels as percentage of CD4+ cells) in healthy 



















































































































Decreased Tregs in Preeclampsia 307
the non corticosteroids using preeclamptic patients. This difference was non-
significant (results not shown). There was no difference in the level of
CD4+FOXP3+ cells in the blood of the women with a vaginal delivery com-
pared with the rest of the respective group.
DISCUSSION
In this study we did not find significantly decreased frequencies of
CD4+CD25highFOXP3+ Treg cells in peripheral maternal blood of preeclamptic
patients. There was however, a clear trend towards decreased frequencies.
Recently, two studies reported that preeclampsia is not associated with
changes in the percentages of CD4+CD25+ cells in peripheral blood (25,26).
Both of these studies used the surface marker CD25 only for the detection of
Treg cells. Our results confirm the similar frequencies of CD4+CD25+ cells
between the control and preeclamptic group. However, surface markers as for
example CD25, CTLA-4,and GITR are also dynamically expressed on the
surface of newly activated CD4+ T-helper cells (29). Therefore it is difficult to
discriminate Treg cells from newly activated T-helper cells based on surface
phenotype alone, especially in pregnancy where there is normal activation of
CD4+ cells in response to paternal allo-antigens expressed by the fetus.
Sasaki et al. reported that levels of CD4+CD25+FOXP3+ are decreased in
peripheral blood and placental tissue of women with preeclampsia (24).
Although we did not find significantly decreased levels of CD4+CD25+FOXP3+
cells, we did find a negative trend in levels of CD4+CD25+FOXP3+ cells in
peripheral blood of pregnancies complicated by preeclampsia. Furthermore,
our study differs in methodology and we measured FOXP3 in a larger number
of preeclamptic patients.
It is known that not only CD4+CD25+FOXP3+ cells but also CD4+CD25-
FOXP3+ cells have a regulatory function, several papers have shown that Treg
cells also can be found in the CD25-Foxp3+ population (30,31). Therefore the
CD4+FOXP3+ population could be regarded as a more satisfactory and com-
plete marker for Treg cells.
In this study we found significantly lower percentages of CD4+ FOXP3+
Treg cells in peripheral blood of women with pregnancies complicated by
preeclampsia compared to healthy pregnant controls. In contrast to the lower
percentages of Treg cells in the peripheral blood, no significant differences of
CD4+FOXP3+ Treg cells were found in umbilical cord blood.
Some studies suggest that during normal pregnancy the maternal immu-
nological shift to a Th2 response takes place to promote tolerance to the fetus
(7,8). It is thought that FOXP3+ Treg cells have an important role in regulating
the immune response and tolerance to the fetus, doing this by suppressing the
maternal immune reaction towards the fetus (8,10,12,13). Treg cells can medi-


















































308 Prins et al.
contact dependent mechanisms (32). These observations together with
the finding that during normal pregnancy the percentages of Treg cells are
increased (8,14), suggest that the lower percentage of FOXP3+ Treg cells we
found in the peripheral blood from women with preeclampsia may reflect
impaired tolerance to the fetus in preeclampsia.
Women with preeclampsia were significantly more often treated with
corticosteriods. Corticosteroids are used to prevent respiratory distress syn-
drome in premature infants. Several studies have found an increase in FOXP3
expression and an increase in the percentages of Treg cells as a result of the
administration of corticosteroids (33,34). The comparison between the groups
and the exposure to steroids would be much better if the possible steroid effect
was avoided. However, because of ethical reasons and logistic circumstances it
was not possible to measure these levels before administration of corticoster-
oids. The increase in the percentage of CD4+FOXP3+ cells in preeclamptic
women using corticosteroids, compared to the non corticosteroids using preec-
lamptic patients suggests that percentages of Treg cells would be lower in
pregnancies complicated by preeclampsia if no corticosteroids had been used.
The gestational age of the pregnancies complicated by preeclampsia was
significantly lower from the gestational age of the healthy controls. As several
studies showed changing levels of regulatory T cells during pregnancy
(14,15,35), a healthy control group with a comparable gestational age to the
preeclamptic pregnancies was included. However, percentages of Treg cells
were comparable in both control groups.
When comparing the percentages of Treg cells between preeclamptic
women and gestational age matched controls we found a lower percentage of
Treg cells in the peripheral blood of women with a pregnancy complicated by
preeclampsia. This confirms that Treg cell percentages are lower in pregnan-
cies complicated by preeclampsia.
Mean Fluorescence Intensity (MFI) describes on a relative scale the
amount of fluorescently labelled antibody which is attached to the antigen.
Recently, using MFI, it was shown that in a mouse model, Foxp3 regulates
Treg cell development and function in a dose-dependent, non-binary manner,
and that decreased Foxp3 expression causes immune disease by subverting
the suppressive function of Treg cells and converting Treg cells into effector
cells (36). Our data on MFI measurements shows no significant differences
between the preeclampsia group and gestational age matched controls
(results not shown).This indicates that the percentage of FOXP3 positive
cells as a fraction of the Treg cells is not different in pregnancies complicated
by preeclampsia.
Our finding that frequencies of CD4+CD25+ cells in peripheral blood were
similar in the preeclamptic and healthy pregnant women suggests that
systemic activation of T cells is not the main dysfunctional mechanism in
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we found in both groups, as it is known that CTLA-4 and GITR are up-
regulated when T cells are activated (13,21,37,38). Furthermore, GITR and
CTLA-4 are involved in the function of Treg cells, the comparable relative
expression of CTLA-4 and GITR we found in Treg cells shows that there are
no large differences in percentages of functional Treg cells. The functional
characteristics of the Treg cells could be further investigated with suppression
assays on maternal blood of patients with preeclampsia.
In umbilical cord blood from pregnancies complicated by preeclampsia we
found significantly higher percentages of CD4+CD25+ cells than in umbilical
cord blood from gestational age matched controls. This finding remains
puzzling, however it could indicate that the increase of CD4+CD25+ cells in
cord blood of fetuses from preeclamptic pregnancies, indicates the increased
inflammatory state of this disease. This would be in line with other studies,
reporting an increase in NK cells and CD8+CD25+ cells in umbilical cord blood
of neonates born to preeclamptic mothers (27,28).
The fetal immune system might be activated by maternal inflammatory
mediators, which could have crossed the placenta. This could be a long-term
influence on the immune system of offspring, therefore a follow-up will be
performed on the offspring of the preeclamptic pregnancies.
In summary, our results demonstrate that preeclampsia is associated with a
low percentage of circulating Treg cells in the mother. However, to imply a causal
role, a decline in Treg cells before the onset of disease, needs to be investigated.
Declaration of Interest: The authors report no conflicts of interest. The
authors alone are responsible for the content and writing of the paper.
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